Understand the source comparison
Best Peptides for Athletes: Performance vs Recovery Comparison
BPC-157 VEGF upregulation, angiogenesis induction Soft tissue repair (tendons, ligaments, muscle strains) 250–500 mcg daily, subcutaneous injection near injury site Subcutaneous Most reproducible evidence for accelerated tendon healing; localized administratio
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- BPC-157
- VEGF upregulation, angiogenesis induction
- Soft tissue repair (tendons, ligaments, muscle strains)
- 250–500 mcg daily, subcutaneous injection near injury site
- Subcutaneous
- Most reproducible evidence for accelerated tendon healing; localized administration shows superior outcomes vs systemic
- TB-500
- Actin upregulation, cellular migration
- Systemic injury recovery, joint inflammation, overuse injuries
- 2–5 mg twice weekly, subcutaneous or intramuscular
- Subcutaneous or intramuscular
- Long half-life allows infrequent dosing; benefits systemic recovery rather than site-specific healing
- CJC-1295 + Ipamorelin
- GH secretagogue receptor agonism, pulsatile GH release
- Recovery optimization, lean mass retention, sleep quality
- CJC-1295 DAC 2 mg weekly; Ipamorelin 200–300 mcg daily before bed
- Preserves natural GH rhythms without axis suppression; most evidence supports nighttime dosing for recovery
- MOTS-c
- AMPK activation, mitochondrial biogenesis
- Metabolic flexibility, endurance capacity, insulin sensitivity
- 5–10 mg 2–3x weekly, subcutaneous
- Strong mechanistic basis in animal models; human trials ongoing; appeals most to endurance athletes
- Semax
- BDNF upregulation, dopamine/serotonin modulation
- Cognitive performance, reaction time, stress resilience
- 300–600 mcg daily, intranasal spray
- Intranasal
- Cognitive rather than physical performance target; most relevant for precision sports requiring sustained focus